Literature DB >> 25038202

Smartphone applications for seizure management.

Puneet Singh Pandher1, Karamdeep Kaur Bhullar2.   

Abstract

Technological advancements continue to provide innovative ways of enhancing patient care in medicine. In particular, the growing popularity of smartphone technology has seen the recent emergence of a myriad of healthcare applications (or apps) that promise to help shape the way in which health information is delivered to people worldwide. While limited research already exists on a range of such apps, our study is the first to examine the salient features of smartphone applications as they apply to the area of seizure management. For the purposes of this review, we conducted a search of the official online application stores of the five major smartphone platforms: iPhone, Android, Blackberry, Windows Mobile and Nokia-Symbian. Apps were included if they reported to contain some information or tools relating to seizure management and excluded if they were aimed exclusively at health professionals. A total of 28 applications met these criteria. Overall, we found an increasing number of epilepsy apps available on the smartphone market, but with only a minority offering comprehensive educational information alongside tools such as seizure diaries, medication tracking and/or video recording.
© The Author(s) 2014.

Entities:  

Keywords:  assistive technologies; ehealth; information technology healthcare evaluation; mobile health; telecare

Mesh:

Year:  2014        PMID: 25038202     DOI: 10.1177/1460458214540906

Source DB:  PubMed          Journal:  Health Informatics J        ISSN: 1460-4582            Impact factor:   2.681


  8 in total

1.  Telemedicine and the challenge of epilepsy management at the time of COVID-19 pandemic.

Authors:  Francesco Brigo; Simona Bonavita; Letizia Leocani; Gioacchino Tedeschi; Luigi Lavorgna
Journal:  Epilepsy Behav       Date:  2020-05-15       Impact factor: 2.937

2.  Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders.

Authors:  Pegah Afra; Carol S Bruggers; Matthew Sweney; Lilly Fagatele; Fareeha Alavi; Michael Greenwald; Merodean Huntsman; Khanhly Nguyen; Jeremiah K Jones; David Shantz; Grzegorz Bulaj
Journal:  Front Hum Neurosci       Date:  2018-05-01       Impact factor: 3.169

3.  Evaluation of E-Health Applications for Paediatric Patients with Refractory Epilepsy and Maintained on Ketogenic Diet.

Authors:  Anna-Maria Costa; Maddalena Marchiò; Giulia Bruni; Silvia Maria Bernabei; Silvia Cavalieri; Marina Bondi; Giuseppe Biagini
Journal:  Nutrients       Date:  2021-04-09       Impact factor: 5.717

4.  Self-Management Apps for People With Epilepsy: Systematic Analysis.

Authors:  Mohsen Zaied Alzamanan; Kheng-Seang Lim; Maizatul Akmar Ismail; Norjihan Abdul Ghani
Journal:  JMIR Mhealth Uhealth       Date:  2021-05-28       Impact factor: 4.773

5.  Quality of Smartphone Apps Related to Panic Disorder.

Authors:  Mathias Van Singer; Anne Chatton; Yasser Khazaal
Journal:  Front Psychiatry       Date:  2015-07-14       Impact factor: 4.157

Review 6.  Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases.

Authors:  Grzegorz Bulaj; Margaret M Ahern; Alexis Kuhn; Zachary S Judkins; Randy C Bowen; Yizhe Chen
Journal:  Curr Clin Pharmacol       Date:  2016

7.  The App Behavior Change Scale: Creation of a Scale to Assess the Potential of Apps to Promote Behavior Change.

Authors:  Fiona H McKay; Sarah Slykerman; Matthew Dunn
Journal:  JMIR Mhealth Uhealth       Date:  2019-01-25       Impact factor: 4.773

Review 8.  Evaluation of M-Health Applications Use in Epilepsy: A Systematic Review.

Authors:  Niloofar Mohammadzadeh; Sahar Khenarinezhad; Ehsan Ghazanfarisavadkoohi; Mohammad Saleh Safari; Shahrbanoo Pahlevanynejad
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.